Is ALTH a good stock to own? Find out who bought Allos Therapeutics, who sold Allos Therapeutics (ALTH) stock, and who holds a large position in Allos Therapeutics.

• Warburg Pincus owns 26.12M shares worth $46.76M
• Wellington Management Company owns 7.70M shares worth $11.39M
• Camber Capital Management owns 4.70M shares worth $6.96M
• HealthCor Management owns 4.50M shares worth $6.66M
• HealthCor Management owns 4.45M shares worth $9.53M
• Vanguard owns 4.36M shares worth $6.45M
• David W. Seeley owns 3.72M shares worth $6.66M
• Duquesne Capital Management owns 2.80M shares worth $12.91M
• Renaissance Technologies owns 2.45M shares worth $4.38M
• Oxford Asset Management owns 2.31M shares worth $4.13M
• Millennium Management owns 2.27M shares worth $3.36M
• Ancora Advisors owns 1.94M shares worth $1.86M
• STATE STREET CORPORATION owns 1.50M shares worth $2.22M
• ARONSON JOHNSON ORTIZ owns 1.50M shares worth $2.68M
• Scopia Management owns 1.33M shares worth $2.38M
• PEAK6 Investments owns 943200 shares worth $1.69M
• T. Rowe Price Associates owns 863100 shares worth $1.54M
• Nomura Holdings owns 820223 shares worth $1.47M
• Altrinsic Global Advisors owns 772480 shares worth $1.38M
• Jacobs Levy Equity Management owns 619557 shares worth $916944
• Geode Capital Management owns 605503 shares worth $896144
• Technical Financial Services owns 572404 shares worth $1.02M
• Raging Capital Management owns 554382 shares worth $787222
• D. E. Shaw & Co owns 476438 shares worth $852824
• Charles Schwab Investment Management owns 428963 shares worth $643444
• Frank Russell Company owns 368941 shares worth $560790
• AQR Capital Management owns 363200 shares worth $650128
• Spark LP/DE owns 311800 shares worth $461464
• Loeb Offshore Management owns 290913 shares worth $520734

• Loeb Arbitrage Management sold on Sept. 30, 2011
• TIAA-CREF Investment Management sold on Sept. 30, 2011
• Capstone Investment Advisors sold on Sept. 30, 2011
• OrbiMed Advisors sold on June 30, 2011
• Broadfin Capital sold on June 30, 2011
• Credit Suisse AG sold on June 30, 2011
• Soros Fund Management sold on June 30, 2011
• WEISS MULTI-STRATEGY ADVISERS sold on June 30, 2011
• Citi sold on June 30, 2011
• Barclays sold on June 30, 2011
• Gerald L. Ray & Associates sold on June 30, 2011
• GOLDMAN SACHS sold on June 30, 2011
• S.A.C. Capital Advisors sold on March 31, 2011
• Columbia Wanger Asset Management sold on March 31, 2011
• Jennison Associates sold on March 31, 2011
• Westfield Capital Management Company sold on March 31, 2011
• Redmile sold on March 31, 2011
• Adage Capital Partners GP sold on March 31, 2011
• Ameriprise Financial sold on March 31, 2011
• Trellus Management Company sold on March 31, 2011
• FMR sold on Dec. 31, 2010
• Sabretooth Capital Management sold on Dec. 31, 2010
• CITADEL ADVISORS sold on Dec. 31, 2010
• Commerzbank Aktiengesellschaft sold on Dec. 31, 2010
• Diamondback Capital Management sold on Sept. 30, 2010
• RHUMBLINE ADVISERS sold on March 31, 2010
• Bill & Melinda Gates Foundation Trust sold on March 31, 2009

• PHH Corporation (PHH)
• Seattle Genetics (SGEN)
• Allos Therapeutics (ALTH)
• Auxilium Pharmaceuticals (AUXL)
• InterMune (ITMN)
• Eli Lilly & Co. (LLY)
• Teva Pharmaceutical Industries (TEVA)
• Vertex Pharmaceuticals Incorporated (VRTX)
• SPDR S&P; 500 ETF (SPY)
• Tenet Healthcare Corporation (THC)
• Cisco Systems (CSCO)
• Boston Scientific Corporation (BSX)
• Intel Corporation (INTC)
• Universal Health Services (UHS)
• Mylan (MYL)
• CareFusion Corporation (CFN)
• Zimmer Holdings (ZMH)
• Wright Medical (WMGI)
• National Penn Bancshares (NPBC)
• Builders FirstSource (BLDR)
• Bridgepoint Education (BPI)